For example, in the monitoring of advanced colorectal cancer, ctDNA enables the dynamic and repeated assessment of changes in multiple key molecules of the tumor, such as EGFR, ERBB2, PIK3CA, and MAP2K1, among others. This evidence concerns the gene PIK3CA and colorectal cancer.